MindWalk Holdings (HYFT) Net Margin (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Net Margin of 0.0% for Q2 2026, down 2.0% year-over-year from 0.0% in Q2 2025, and up 28.55% quarter-over-quarter from 0.0% in Q4 2025.
Powered by 
Analysis
MindWalk Holdings (HYFT) Net Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Net Margin for 7 consecutive years, with 0.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Margin fell 2.0% year-over-year to 0.0%; the TTM figure through Apr 2026 stood at 13.74% (up 1140.0% YoY), while the FY2026 annual figure was 7.41%, down 2000.0% from the prior year.
- Net Margin improved to 0.0% in Q2 2026 per HYFT's latest filing, from 0.0% in the prior quarter.
- Across five years, Net Margin topped out at 73329.82% in Q3 2023 and bottomed at 792.14% in Q2 2023.
- Historically, Net Margin has averaged 8075.72% across 5 years, with a median of 15.8% in 2025.
- Annual changes were most pronounced in 2022 — Net Margin jumped 2000000000 bps — and 2024, when it plunged 7332120 bps.
- MindWalk Holdings' Net Margin stood at 100.81% in 2022, then soared by 28369 bps to 28699.19% in 2023, then plunged by 100 bps to 37.1% in 2024, then slumped by 100 bps to 0.0% in 2025, then increased by 29 bps to 0.0% in 2026.
- Business Quant data shows HYFT's Net Margin at 0.0% in Q2 2026, 0.0% in Q4 2025, and 35716.55% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 12.09% |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -3.12% |
| 10 | MindWalk Holdings | 60.76 Mn | 52.48 Mn | 1.82 Mn | -83.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -83.13% |
| Jan 31, 2026 | -88.79% |
| Oct 31, 2025 | -66.10% |
| Jul 31, 2025 | 43.97% |
| Apr 30, 2025 | -270.05% |
| Jan 31, 2025 | -1,005.90% |
| Oct 31, 2024 | -141.51% |
| Jul 31, 2024 | 0.00% |
| Apr 30, 2024 | 306.12% |
| Jan 31, 2024 | -66.20% |
| Oct 31, 2023 | -48,829.27% |
| Jul 31, 2023 | -71,192.25% |
| Apr 30, 2023 | -140.17% |
| Jan 31, 2023 | -86.56% |
| Oct 31, 2022 | -141.80% |
| Jul 31, 2022 | -206.21% |
| Apr 30, 2022 | -101.32% |
| Jan 31, 2022 | -93.77% |
| Oct 31, 2021 | -102.59% |
| Jul 31, 2021 | -79.66% |